Category Archives: Cbd Oil

LONGMONT, Colo. (PRWEB) March 30, 2021

Canna Comforts, a market leader in hemp CBD extract products, is celebrating its continued growth as it pursues its mission to deliver the finest all-natural cannabidiol products on earth to help those who need it most.

Now in its fifth year of business, Canna Comforts has expanded its operations beyond Colorado and continues to pride itself on cooking the highest quality Hemp CBD with the most cannabinoids possible. Canna Comforts works with the best hand harvested, whole plant cured, machine & hand trimmed Hemp CBD flowers. Its plant genetics come from Colorado, Oregon, and California, and include a mix of Canna Comforts homegrown product and that of trusted farmers.

As a pioneering company in the CBD industry, Canna Comforts faced a number of legal hurdles, yet continues to thrive. Today, the market leader is excited to offer a variety of products ranging from CBD Infused Bath Bombs and CBD oil, to raw hemp flowers, concentrates and more, offering various ways for consumers to live a better and healthier life using natures medicine.

I battled cancer and found cannabinoids from industrial hemp as the best solution to help me get through chemotherapy and back to a normal life, explained Jamie Evans, Canna Comforts Co-Owner & Founder. It wasnt long before others also confirmed that our products actually work and help - we knew we couldnt stop.

Canna Comforts was formed to help those in need of an all-natural alternative and it is this mission that will continue to guide us for years to come, added Monica Stubbs, Co-Owner & CEO.

Canna Comforts values collaboration with fellow small businesses and works collectively to bring quality made in the US products to its consumers. All their products are manufactured from their own grows and never from imported materials.

Whether customers are looking for something to help manage emotional, mental and physical conditions, Canna Comforts is thrilled to deliver products that improve their quality of life. Canna Comforts products are sold throughout the U.S. and are now available at https://cannacomforts.com.

About Canna Comforts Canna Comforts aims to offer the finest all-natural cannabidiol products on earth to help those who need it most. Via partnerships with farmers across several U.S. states, Canna Comforts is proud to deliver the highest quality Hemp CBD with the most cannabinoids possible with a range of products that improve the quality of life of others, and continues to formulate true medicinal cannabinoids.

FOR FURTHER INFORMATION PLEASE CONTACT:Sales@cannacomforts.com720.498.1061

Share article on social media or email:

Excerpt from:

Canna Comforts continues to expand with its focus on Hemp CBD products that heal - PR Web

U.S. hemp oil market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing at a CAGR of 26.8% in the forecast period of 2020 to 2027 and expected to reach USD 4,906.54 thousand by 2027. Hemp oil market is dominating as people are becoming more health conscious and they prefer organic product which is good for health.

An influential U.S. hemp oil Market report puts emphasis on key market dynamics of the U.S. hemp oil Market industry and provides historic data, present market trends, environment, technological innovation, upcoming technologies and therefore the technical progress within the allied industry. Furthermore, this Market research report presents thorough summary of the market where it finds out industry trends, determines brand awareness and influence, gives industry insights and offers competitive intelligence. While forming this business report, systematic gathering and analysis of data about individuals or organizations has been conducted through social and opinion research. With the wide ranging U.S. hemp oil Market report businesses can construct a robust organization and make better decisions that take business towards the good level of success.

Ask for Sample Copy of This Report: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=us-hemp-oil-market

U.S. hemp oil market Scenario

Few of the major competitors currently working in the global hemp oil market are Isodiol International Inc, HempLife Today, Hemp Oil Canada Inc, Medical Marijuana, Inc., FOLIUM BIOSCIENCES, CV Sciences, Inc., Pharmahemp d.o.o., Gaia Botanicals, LLC, Canazil, Kazmira, Spring Creek Labs, Cavendish Nutrition Fulfillment LLC, Dr. Hemp Me., QC Infusion, Hemp Production Services, Hudson Valley Hemp, LLC., Green Roads, Royal CBD, Moon Mother Hemp Company, CBD Oil Europe, , King CBD Company and others.

To thrive during this rapidly transforming marketplace, todays businesses involve innovative and superlative solutions. Businesses can accomplish an unmatched insights and expertise of the simplest U.S. hemp oil Market opportunities into their relevant markets with the assistance of this Market research report. This market report gives clear idea about the market potential for every countryside supported the expansion rate, macroeconomic parameters, consumer buying patterns, possible future trends, and market demand and provide scenarios. The credible U.S. hemp oil Market research report covers Market research , market definition, market segmentation, key developments within the market, key players or competitor analysis and detailed research methodology.

Attaining knowledgeable information about the trends and opportunities within the industry is sort of a time consuming process. However, global U.S. hemp oil Market research report cracks this problem very quickly and simply . This market report has been structured by thoroughly comprehending specific needs of the business. The report precisely collects the info and knowledge about valuable factors for the U.S. hemp oil Market industry which range from customer behavior, emerging trends, product usage, and brand positioning. the knowledge of an all-inclusive U.S. hemp oil Market report not only helps business craft data-driven decisions but also assures maximum return on investment (ROI).

Heres how Data Bridge Market research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The how Data Bridge researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the knowledge is compiled and included within the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor results in the estimation of the U.S. hemp oil Market size and also provides an overview about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the continued and upcoming investment opportunities across a specific market. These developments make the stakeholders conscious of the present investment scenario across the U.S. hemp oil Market.

And More..Get Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=us-hemp-oil-market

.

Key Questions Answered within the U.S. hemp oil Market Report:

5.MARKET SEGMENTATION

COMPETITIVE LANDSCAPE

*List Not Exhaustive

Get Enquiry About This Comprehensive Report @: https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=us-hemp-oil-market

View original post here:

US hemp oil Market: Current Market Scenario And Industry Forecasts 2021-2027|| Know the Companies List Could Potentially Benefit or Loose out From the...

Bloomberg

(Bloomberg) -- From his perch high above Midtown Manhattan, just across from Carnegie Hall, Bill Hwang was quietly building one of the worlds greatest fortunes.Even on Wall Street, few ever noticed him -- until suddenly, everyone did.Hwang and his private investment firm, Archegos Capital Management, are now at the center of one of the biggest margin calls of all time -- a multibillion-dollar fiasco involving secretive market bets that were dangerously leveraged and unwound in a blink.Hwangs most recent ascent can be pieced together from stocks dumped by banks in recent days -- ViacomCBS Inc., Discovery Inc. GSX Techedu Inc., Baidu Inc. -- all of which had soared this year, sometimes confounding traders who couldnt fathom why.One part of Hwangs portfolio, which has been traded in blocks since Friday by Goldman Sachs Group Inc., Morgan Stanley and Wells Fargo & Co., was worth almost $40 billion last week. Bankers reckon that Archegoss net capital -- essentially Hwangs wealth -- had reached north of $10 billion. And as disposals keep emerging, estimates of his firms total positions keep climbing: tens of billions, $50 billion, even more than $100 billion.It evaporated in mere days.Ive never seen anything like this -- how quiet it was, how concentrated, and how fast it disappeared, said Mike Novogratz, a career macro investor and former partner at Goldman Sachs whos been trading since 1994. This has to be one of the single greatest losses of personal wealth in history.Late Monday in New York, Archegos broke days of silence on the episode.This is a challenging time for the family office of Archegos Capital Management, our partners and employees, Karen Kessler, a spokesperson for the firm, said in an emailed statement. All plans are being discussed as Mr. Hwang and the team determine the best path forward.The cascade of trading losses has reverberated from New York to Zurich to Tokyo and beyond, and leaves myriad unanswered questions, including the big one: How could someone take such big risks, facilitated by so many banks, under the noses of regulators the world over?One part of the answer is that Hwang set up as a family office with limited oversight and then employed financial derivatives to amass big stakes in companies without ever having to disclose them. Another part is that global banks embraced him as a lucrative customer, despite a record of insider trading and attempted market manipulation that drove him out of the hedge fund business a decade ago.A disciple of hedge-fund legend Julian Robertson, Sung Kook Bill Hwang shuttered Tiger Asia Management and Tiger Asia Partners after settling an SEC civil lawsuit in 2012 accusing them of insider trading and manipulating Chinese banks stocks. Hwang and the firms paid $44 million, and he agreed to be barred from the investment advisory industry.He soon opened Archegos -- Greek for one who leads the way -- and structured it as a family office.Family offices that exclusively manage one fortune are generally exempt from registering as investment advisers with the U.S. Securities and Exchange Commission. So they dont have to disclose their owners, executives or how much they manage -- rules designed to protect outsiders who invest in a fund. That approach makes sense for small family offices, but if they swell to the size of a hedge fund whale they can still pose risks, this time to outsiders in the broader market.This does raise questions about the regulation of family offices once again, said Tyler Gellasch, a former SEC aide who now runs the Healthy Markets trade group. The question is if its just friends and family why do we care? The answer is that they can have significant market impacts, and the SECs regulatory regime even after Dodd-Frank doesnt clearly reflect that.Valuable CustomerArchegos established trading partnerships with firms including Nomura Holdings Inc., Morgan Stanley, Deutsche Bank AG and Credit Suisse Group AG. For a time after the SEC case, Goldman refused to do business with him on compliance grounds, but relented as rivals profited by meeting his needs.The full picture of his holdings is still emerging, and its not clear what positions derailed, or what hedges he had set up.One reason is that Hwang never filed a 13F report of his holdings, which every investment manager holding more than $100 million in U.S. equities must fill out at the end of each quarter. Thats because he appears to have structured his trades using total return swaps, essentially putting the positions on the banks balance sheets. Swaps also enable investors to add a lot of leverage to a portfolio.Morgan Stanley and Goldman Sachs, for instance, are listed as the largest holders of GSX Techedu, a Chinese online tutoring company thats been repeatedly targeted by short sellers. Banks may own shares for a variety of reasons that include hedging swap exposures from trades with their customers.Unhappy InvestorsGoldman increased its position 54% in January, according to regulatory filings. Overall, banks reported holding at least 68% of GSXs outstanding shares, according to a Bloomberg analysis of filings. Banks held at least 40% of IQIYI Inc, a Chinese video entertainment company, and 29% of ViacomCBS -- all of which Archegos had bet on big.Im sure there are a number of really unhappy investors who have bought those names over the last couple of weeks, and now regret it, Doug Cifu, chief executive officer of electronic-trading firm Virtu Financial Inc., said Monday in an interview on Bloomberg TV. He predicted regulators will examine whether there should be more transparency and disclosure by a family office.Without the need to market his fund to external investors, Hwangs strategies and performance remained secret from the outside world. Even as his fortune swelled, the 50-something kept a low profile. Despite once working for Robertsons Tiger Management, he wasnt well-known on Wall Street or in New York social circles.Hwang is a trustee of the Fuller Theology Seminary, and co-founder of the Grace and Mercy Foundation, whose mission is to serve the poor and oppressed. The foundation had assets approaching $500 million at the end of 2018, according to its latest filing.Its not all about the money, you know, he said in a rare interview with a Fuller Institute executive in 2018, in which he spoke about his calling as an investor and his Christian faith. Its about the long term, and God certainly has a long-term view.His extraordinary run of fortune turned early last week as ViacomCBS Inc. announced a secondary offering of its shares. Its stock price plunged 9% the next day.The value of other securities believed to be in Archegos portfolio based on the positions that were block traded followed.By Thursdays close, the value of the portfolio fell 27% -- more than enough to wipe out the equity of an investor who market participants estimate was six to eight times levered.Its also hurt some of the banks that served Hwang. Nomura and Credit Suisse warned of significant losses in the wake of the selloff and Mitsubishi UFJ Financial Group Inc. has flagged a potential $300 million loss.You have to wonder who else is out there with one of these invisible fortunes, said Novogratz. The psychology of all that leverage with no risk management, its almost nihilism.(Updates with latest bank to detail exposure in penultimate paragraph.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.2021 Bloomberg L.P.

Read the original:

CBD of Denver Inc. (CBDD) Becomes One of the First CBD Companies to Accept Bitcoin and Other Crypto Currencies - Yahoo Finance

Denver, Colorado, March 30, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- CBD Global Sciences, Inc. (OTC: CBDNF) (CSE: CBDN) (Frankfurt:GS3), (CBD Global or the Company), is pleased to announce the addition of new brands to its CBD products distribution channel.

Legacy Distribution Group, Legacy Distribution (Denver, CO) is one of the countrys first CBD-only Direct Store Delivery (DSD) distributors. CBD Globals Legacy Distribution Group is excited to announce the addition of Marley CBD (Docklight Brands) to its family of brands. Legacy will be carrying the full line of Marley CBD beverage products and is excited to add the already outstanding success of the brand to its growing lineup of CBD infused brands.

Brad Wyatt, CEO of CBD Global, shared, The team at Legacy Distribution has done a phenomenal job in the rapid growth of the distribution channel, not only with adding quality CBD vendors such as Marley but in the growth of points of distribution. We are adding new trucks and drivers to support the new routes weekly, all very exciting! We look forward to continuing to add new distribution points with Legacy Distribution.

About Docklight Brands, Inc.

Docklight Brands is a pioneering consumer brand company crafting the futures of the rapidly emerging, legal cannabis and cannabinoid industries. Docklights focus is on building lasting cannabis and hemp-derived brands that consumers crave. Docklight uses their deep understanding of consumer needs states and category trends, to create brands that resonate with consumers and are among the bestselling cannabis and hemp-derived brands on the market ( http://www.docklightbrands.com ).

ABOUT CBD GLOBAL SCIENCES INC.

CBD Global Sciences, Inc., is a vertically integrated hemp-based CBD producer and branding investment vehicle which currently owns two product categories, branded under the name Aethics (www.aethics.com) and CANNAOIL (www.cannaoilshop.com), which include CBD Oil tinctures (liquid products), CBD capsules, CBD topicals, Hydration products and Confectionary products. CBD Global Sciences hemp-derived CBD extracts are sold through select distributors, brick and mortar retailers, and online. With its newly formed Legacy Distribution it has begun to penetrate markets with little to no CBD on the shelves and is becoming the premier path to market for many widely known CBD infused brands.

Story continues

CBD Global Sciences, through its wholly owned subsidiary, Strasburg Pharms, grows and operates irrigated land in Colorado, that grows hemp with only all-natural Colorado water, soil, sun and nutrients and NEVER sprayed with pesticides or chemicals. Our genetics are hand selected and maintained to present the best cannabinoid profile with extremely high CBD.

For further information, please contact Investor Relations, (888) 401-2239, info@cbdglobalsciences.com

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAS REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to future developments and the business and operations of the Corporation after the CSE listing. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to general business, economic, competitive, political, and social uncertainties; and delay or failure to receive board, shareholder or regulatory approvals. Readers should not place undue reliance on forward-looking statements. The Corporation disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Go here to see the original:

Legacy Distribution Group, a Subsidiary of CBD Global Sciences, to Begin Distribution for Docklight Brands Inc. - Yahoo Finance

Cannabidiol, the supremely popular cannabis compound touted as a general wellness cure-all known as CBD, may be effective in treating cocaine addiction, according to recent research.

Unlike dependence on opiates or alcohol, there are no pharmaceutical treatments for addiction to cocaine, which the National Institutes on Drug Abuse calls powerfully addictive. (Whether its the substance itself, the experiences of the user, or a combination of the two that leads someone down the path to the chronic disease known as addiction is a separate question.)

Building on other preclinical research that suggests cannabidiol (or CBD) may be useful in treating cocaine dependency, scientists in Spain discovered that lab mice treated with CBD were less likely to start re-using cocaine after a period of non-use, even after they were exposed to triggers associated with re-use.

These results suggest that CBD could reduce reinstatement to cocaine-seeking after a period of abstinence, the researchers wrote in findings published earlier this month in the Journal of Psychopharmacology.

While cautioning that the results are very preliminaryand contradict other recent research into CBD treatments for cocaine addiction, conducted in humansresearchers not involved with the study contacted for this article agreed that the findings suggest CBD may be a valuable tool in treating a variety of substance-abuse disorders. They also agree that research also supports anecdotes from treatment centers as well as cannabis advocates who tout cannabis as a replacement therapy for people trying to wean themselves off of other, far more dangerous drugs.

This study is consistent with a growing body of animal research suggesting a role for CBD across various addictive spectrum disorders including stimulant use disorders like cocaine and amphetamine, said Stephen Ross, a physician and associate professor of psychiatry at New York Universitys Grossman School of Medicine, where he is a co-director of psychedelic research. This preclinical study helps set the stage for the use of CBD to treat cocaine use disorders in humans.

In the study, psychologists and psychobiologists at the University of Valencia and the Carlos III Health Institute in Madrid investigated two triggers: a stressor called social defeat and cocaine priming, in which lab mice with a habit were given a dose and then left to see whether they would re-use. In both instances, CBD blocked this stress-induced reinstatement, researchers found.

See Also: Big Weed Is Here: Marijuana Legalization Spreads, Budding Big Business Green

More notably, perhaps, was that CBD seemed to reverse a change in the mices dopamine neurons associated with cocaine priming. Drug abuse is known to change brain chemistry to encourage more use; could CBD reverse the brain reprogramming that leads a user to become addicted?

Possibly, but also maybe not. (This is how preliminary research works.) In a separate study, 40 adults with moderate to severe cocaine-use disorder were given an 800-milligram daily CBD treatment. And all but three participants relapsed to cocaine, according to findings published by Canadian researchers in the journal Addiction. Despite this, researchers contacted for this article maintained that CBD still has promise in addiction treatment.

The fact that one study in humans did not show positive findings does not necessarily mean that cannabidiol is not helpful, said Dr. Ziva Cooper, research director at the Cannabis Research Institute at the University of California, Los Angeles. The take-home message here, really, is that were in the infancy of this research, in understanding how CBD might be helpful for substance-use disorder.

The mice study that found CBD was helpful in reducing re-use among mice exposed to stress might mean that CBD could help humans for whom anxiety is a trigger for re-use. The mice study is a nice positive signal that adds to the evidence that CBD might be helpful in reducing some aspects that lead to relapse, Cooper added.

The study does not mean that smoking weed or taking whatever CBD concoction thats available online or at your local wellness merchant is a viable addiction-treatment option. There are vast differences between cannabis flower strains high in CBD as well as between CBD oilnone of which are regulated by the Food and Drug Administration. Still, for addiction-treatment clinicians without any chemical interventions available, CBD holds some promise. And with interest in the cannabis compound still booming, more studies will follow.

Go here to read the rest:

CBD Could Be A Key to Treating Addiction Long-Term, Studies Show - Observer

DUBLIN, March 24, 2021 /PRNewswire/ -- The "Cannabidiol Market Size, Share & Trends Analysis Report 2021-2028" report has been added to ResearchAndMarkets.com's offering.

The global cannabidiol market size is expected to reach USD 13.4 billion by 2028. The market is expected to expand at a CAGR of 21.2% from 2021 to 2028.

Increasing awareness about the health benefits of cannabidiol (CBD), changing consumer opinion, and attitude toward CBD products are some of the key factors driving the demand for these products. Furthermore, increasing demand for cannabidiol from various end-user industries such as food and beverage, personal care and cosmetics, and pharmaceuticals is expected to trigger market growth.

The recent COVID-19 pandemic has affected many industries around the world, including the CBD industry. The impact of COVID-19 has led to disruption in production processes, due to strict quarantine measures taken across the globe, there is a stagnation in the supply of products, including CBD products. In addition, most of the retail stores are currently closed due to the pandemic. Hence, the marketplace may face a slowdown amidst the pandemic, however, it can gain momentum in 2021, due to the increase in demand for CBD-based products in the coming years.

In 2020, the hemp segment accounted for the largest revenue share valued at USD 1.7 billion, owing to the rising awareness regarding the health benefits of products infused with cannabidiol derived from marijuana. On the other hand, hemp-derived CBD is expected to witness the fastest CAGR over the forecast period, owing to the increasing legalization of hemp in various countries.

The Business to Business (B2B) segment accounted for the largest revenue share in 2020 and is expected to witness a lucrative growth rate over the forecast period. Growing demand for cannabidiol products in various sectors such as health and wellness, pharmaceutical, food and additives, and cosmetics sectors has increased the need for companies to procure cannabidiol raw material or precursor material for their product in bulk. Hence, various growth opportunities are emerging in the cannabidiol wholesale business, which is expected to propel the growth of this segment.

North America dominated the market in 2020 and is expected to continue its dominance over the forecast period. Favorable regulations, increasing awareness about CBD oil, growing consumer preference, and a rise in the number of manufacturers are factors expected to fuel market growth in the region.

Cannabidiol Market Report Highlights

Key Topics Covered:

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

Chapter 3 CBD Market Variables, Trends & Scope3.1 Market Segmentation (Global Cannabidiol (CBD) Market)3.2 Global Cannabis Extracts Trade Route3.3 Global Cannabis Extracts Demand and Supply Analysis3.4 Penetration & Growth Prospects Mapping3.5 Cannabis Regulatory Scenario, By Country3.5.1 U.S.3.5.1.1 Cultivation/Production3.5.1.2 Legal Status (CBD & THC)3.5.1.3 Regulatory Bodies Involved3.5.2 Canada3.5.3 Germany3.5.4 Italy3.5.5 Croatia3.5.6 Netherlands3.5.7 Czech Republic3.5.8 Poland3.5.9 Switzerland3.5.10 Australia3.5.11 Israel3.5.12 Uruguay3.5.13 Colombia3.5.14 Argentina3.5.15 Chile3.6 Market Dynamics3.6.1 Market Driver Analysis3.6.1.1 Growing legalization of cannabis-based CBD products3.6.1.2 Increasing preference towards cannabis extracts such as oils and tinctures3.6.1.3 Growing adoption of CBD-based products for treating various medical conditions3.6.1.4 Rise in the number of retailers selling CBD-based products3.6.2 Market Restraint Analysis3.6.2.1 Stringent government regulations3.6.2.2 Absence of legalization programs in several asian and african countries3.6.2.3 High cost of CBD in leading markets3.6.3 Industry Challenges3.7 Cannabidiol (CBD) - Porter's Analysis3.8 Cannabidiol (CBD) - PESTEL Analysis3.9 Opportunity Analysis (2016-2020-2028)3.10 Import/Export Scenario, by Country3.11 Product Adoption Pattern Analysis3.12 Value Chain Analysis3.12.1 Raw Material Trends3.12.1.1 Market price evolution of biomass commodity cost (to processor)3.12.1.2 Manufacturing Trends3.13 Average Selling Price of Cannabidiol, by Country3.14 Key End Users3.14.1 U.S. Market Scenario3.15 COVID-19 Impact Analysis

Chapter 4 Cannabidiol (CBD) Market: Source Type Estimates & Trend Analysis4.1 Cannabidiol (CBD) Market Size & Forecasts And Trend Analysis By Source, 2016 - 2028, (USD Million)4.1.1 Hemp4.1.2 Marijuana

Chapter 5 Cannabidiol (CBD) Market: Distribution Channel Estimates & Trend Analysis5.1 Cannabidiol (CBD) Market, By Distribution Channel Analysis5.2 Business to Business (B2B)5.3 Business to Consumer (B2C)5.3.1 Hospital Pharmacies5.3.2 Online Stores5.3.3 Retail Stores

Chapter 6 Cannabidiol (CBD) Market: End-use Estimates & Trend Analysis6.1 Cannabidiol (CBD) Market, By End Use Analysis6.2 Medical6.2.1 Chronic Pain6.2.2 Mental Disorders6.2.3 Cancer6.2.4 Others6.3 Personal Use6.4 Pharmaceutical6.5 Wellness6.5.1 Food & Beverages6.5.2 Personal Care & Cosmetics6.5.3 Nutraceuticals

Chapter 7 Cannabidiol (CBD) Market: Regional Estimates & Trend Analysis7.1 Global Cannabidiol Market Share, By Region, 2020 & 2028

Chapter 8 Competitive Landscape

For more information about this report visit https://www.researchandmarkets.com/r/7a2ib8

Media Contact:

Research and Markets Laura Wood, Senior Manager [emailprotected]

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

http://www.researchandmarkets.com

Link:

Global $13.4 Billion Cannabidiol Market to 2028 - Increasing Awareness CBD Health Benefits, Changing Consumer Opinion, and Attitude Toward CBD...

NEW YORK, March 24, 2021 /PRNewswire/ -- With CBD being found in an assortment of products, due to its sought-after relaxing properties, the demand for CBD has gone global. The use of CBD has also been a debatable topic in mainstream news these days. The cannabis and CBD food market has projected that the industry will be worth $6.6 billion by 2024, and it's obvious this is due to the growing intrigue of consumers worldwide. Cannabis has also been legalized for medical use in major countries like Australia, Canada, Germany, Italy, and parts of the United States, to name a few. Companies such as Pure Extracts Technologies Corp. (CSE:PULL) (OTCPK:PRXTF) (XFRA: A2QJAJ), Canopy Growth Corporation (NASDAQ:CGC) (TSX:WEED),Aleafia Health Inc. (TSX:AH) (OTCQX:ALEAF),OrganiGram Holdings (NASDAQ:OGI) (TSX:OGI),and Khiron Life Sciences (TSXV:KHRN) (OTCQB:KHRNF)have tapped into international markets as well, leading to a broader awareness of CBD.

Pure Extracts Advances to European Market With CBD Oil Extracts

Pure Extracts Technologies Corp. (CSE:PULL) (OTC:PRXTF) (XFRA: A2QJAJ), a plant-based extraction company, recently announced its entry into the international market after selling its first batch of cannabis oil extracts to a German-based pharmaceutical company. Pure Extracts extracted its CBD oil from Canadian grown, EU-GMP certified, dry cannabis flower resulting in 75% pure THC full spectrum oil (FSO) and 88% pure THC distillate. In the future, the FSO and distillate will be processed in Germany into an ultra-pure form of THC for medical purposes.

Pure ExtractsCEO, Ben Nikolaevsky, spoke about its entry into the international market, stating, "it is gratifying to have had our concentrates selected by a German pharmaceutical company for use in their medical products. We are excited about the entire European market opportunity for our extracts."

Pure Extracts recognizes the potential of this initial sale as it paves the way for long-term supply agreements with Germany. Furthermore, this professional relationship with one of Europe's most lucrative markets offers the opportunity for future agreements with other European countries that have legalized cannabis.

Ahead for Pure Extracts is its most recent venture, which includes the innovative Cosolvent Injection System (CIS) from Vitalis Extraction Technology Inc. This advanced system is limited in quantity, and Pure Extracts will be one of the first few companies in the world to acquire this technology. With Pure Extracts and Vitalis having a long-term partnership, the use of the CIS technology was developed to enhance the Vitalis carbon dioxide extraction systems in order to produce higher-quality cannabis extracts with faster run times. Now, Pure Extracts will utilize the same technology for its own production of cannabis extracts.

CBD Excitement Leads to Innovative Products in the Expanding Market

Canopy Growth Corporation (NASDAQ:CGC) (TSX:WEED) will expand its presence in North America by introducing its innovative sparkling CBD waters in four different flavors. However, the company is looking at a launch prior to the federal legalization of cannabis in the United States. The Ontario-based cannabis company had previously launched its sparkling beverages in Canada in the fall of 2020. The drinks contain 20mg of CBD ranging from flavors such as ginger lime, cucumber mint, blueberry acai, and guava passion fruit.

Aleafia Health Inc. (TSX:AH) (OTC:ALEAF) formulated its own version of a CBD oil, which contains a high component of the cannabis plant in its oil product. Consistent with the effects of relaxation found in a majority of CBD products, the Aleafia products are being marketed as Symbl High CBD 50, and as Emblem CBD 50 for medical use. Although the CBD oils launched in December 2020, it has been noted they are currently not as widely available in Canada due its high potency levels.

OrganiGram Holdings (NASDAQ:OGI) (TSX:OGI) has also entered the international market after spending an extended period of time scoping out a strategic partnership that included consumer packaged goods, beverage, and alcohol companies. As a result, OrganiGram entered into a partnership with British American Tobacco (BAT). The agreement states the focus will initially be placed on CBD, but the overall aim is to develop the next generation of cannabis products. OrganiGram has also delved into other areas such as the production of high quality chocolates that contain CBD.

Last summer, Khiron Life Sciences (TSXV:KHRN) (OTCQB:KHRNF)announced its plans to export high-CBD medical products from Colombia, followed by importing and commercializing them in Peru. Khiron established its plan by completing all necessary licensing, importing, and distribution requirements. Khiron Colombia made an agreement with Farmacia Universal, which entailed that the CBD medical cannabis would be supplied by Khiron Colombia and then manufactured and distributed by Farmacia Universal.

As companies like Pure Extracts explore new avenues for their products, the cannabis industry seems set to continue expansion as projected for the coming years ahead.

For more information on Pure Extracts Technologies, click here.

DISCLAIMER: Microsmallcap.com (MSC) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. FN Media Group (FNM) is a third-party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated with MSC or any company mentioned herein. The commentary, views and opinions expressed in this release by MSC are solely those of MSC and are not shared by and do not reflect in any manner the views or opinions of FNM. Readers of this Article and content agree that they cannot and will not seek to hold liable MSC and FNM for any investment decisions by their readers or subscribers. MSC and FNM and their respective affiliated companies are a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author (MSC), and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author (MSC) has not independently verified or otherwise investigated all such information. None of the Author, MSC, FNM, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer's filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer's securities, including, but not limited to, the complete loss of your investment. FNM was not compensated by any public company mentioned herein to disseminate this press release but was compensated twenty five hundred dollars by MSC, a non-affiliated third party to distribute this release on behalf of Pure Extracts.

FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and MSC and FNM undertake no obligation to update such statements.

Media Contact:FN Media Group, LLC[emailprotected]+1(561)325-8757

SOURCE Microsmallcap.com

See original here:

Hemp is Becoming a Global Business As Market Projects Big Gains By 2024 - PRNewswire

If you are of my generation, you have strong memories of Jane Fonda, as an actress and as an activist.

But it really startled me the other day to see this article in Longevity saying that Jane Fonda is 83. Whats the secret to her agelessness? Well, one thing she attributes it to is CBD oil.

Without question, the right supplements can be beneficial for some people with MCI.

Which is great for Jane Fonda, but is CBD oil right for people with mild cognitive impairment? Ive been getting that question a lot lately, so thats what I want to talk about today.

Hi, Im Tony Dearing of GoCogno.com, the website for people with mild cognitive impairment.

Now without question, the right supplements can be very beneficial for some people with MCI. On that list, I would put things like fish oil. And MCT oil.

But CBD oil? Sorry, I cant recommend that one to people with MCI. The evidence isnt there yet. Still, I dont dismiss it entirely.

CBD (cannabidiol) is one of the active ingredients in marijuana. And it has legitimate medicinal benefits. As Harvard Health points out, its used to treat certain child epilepsy syndromes. And also, such conditions as anxiety, insomnia and chronic pain.

But when people with mild cognitive impairment ask me about CBD oil, I point them to the Cognitive Vitality website.

However, most clinical studies have shown a lack of cognitive improvement.

According to the Cognitive Vitality report on CBD oil: Studies have suggested potential neuroprotective properties of CBD. However, most clinical studies have shown a lack of cognitive improvement, and no data exist for long-term treatment in humans.

Now, because CBD has shown to be helpful in treating anxiety and sleeplessness, there is a potential secondary benefit. For someone with MCI, if youre feeling less anxious or if youre sleeping better, youre likely to do better cognitively.

However, if your specific concern is brain health, and giving yourself the best possible chance to slow, halt or reversing whatever cognitive loss youre experiencing, theres much better evidence for supplements like MCT oil, or fish oil, or Lions Mane mushrooms or curcumin.

Hype isnt going to make your brain better. You want something thats safe and scientifically proven.

So yeah, theres a lot of buzz right now around CBD oil. But hype isnt going to make your brain better. You want something thats safe and scientifically proven, and of course, you always want to talk to your doctor about any supplement or vitamin youre considering.

So thats my take on CBD oil. I hope you find it helpful, and if you want to know more, Im including a bunch of helpful links below. Thanks again for joining me today. Ill see you again next week. Until then, as always, be kind to your mind.

Continue reading here:

CBD oil and MCI here's what you need to know - GoCogno.com

A mum has told how drops of cannabis oil from a company started by two Paisley brothers has changed her life after suffering years of excruciating pain.

Kelly Tweedies agonising ordeal began during her second pregnancy when she developed SPD symphysis pubis dysfunction a condition that causes a debilitating pain in the hips, back and upper legs.

It was so bad, Kelly, 37, spent six months of her pregnancy having to use crutches to get around.

Although for many women the condition improves and disappears after giving birth, Kelly continued to suffer the chronic pain SPD brings for nine years after her son, Alfie was born.

Kelly also has a daughter, Ava, aged 12, but she went through so much pain, it even stopped her having the third child she wanted, as she couldnt bear the agony of severe SPD during pregnancy again.

Neither over-the-counter painkillers, nor stronger tablets that were prescribed by her doctor managed to control Kellys pain.

But that all changed last summer when she started taking half-a-dozen drops of Nutrivive CBD oil under her tongue every day.

Kelly is now free from the pain and has almost completed a training programme that takes her from the couch to running a distance of 5k.

She now even wants to take part in a fun run to raise money for charity.

Nutrivive is a Paisley-based company launched last year by brothers John and Harry McDonough and their premium CBD oil contains cannabidiol, which is the part of the cannabis plant with pain relieving, calming and healing properties.

The oil is legal, safe and non-addictive, as it doesnt contain the THC compound that gives the high associated with smoking cannabis, or taking the drug in other forms. Medical cannabis was legalised in the UK in November 2018.

The Scottish Governments Healthcare Improvement Scotland yesterday announced they have authorised the countrys first medical cannabis clinic, in Stirling.

Kelly, a former midwife explains how the crippling pain from the SPD affected her and how Nutrivive CBD oil has had an amazing effect on her life:

SPD is a condition that is very under-recognised for the amount of pain it can cause.

I was on crutches after being six months pregnant with Alfie. The pain in my hips was unbelievable.

At first I wore a belt during the day to help with the pain, but it got so bad I had no option but to get about on crutches.

My legs wouldnt move like I wanted them to and it would take me ages to do something simple and straightforward as get out of bed.

I would have had another child if it wasnt for the pain I suffered during my second pregnancy.

Its a horrible pain and I wouldnt wish it on anyone. I now wish Nutrivive was around after I gave birth to Alfie.

Kelly continued: Even after Alfie was born, the pain never really went away and sometimes it would be just about bearable and I would put up with it. But whenever Id take part in any physical activity it would flare up again and would last for weeks at a time.

I had physiotherapy, but that didnt cure the problem.

I resigned myself that I wasnt going to be cured of the pain and tried to accept that I had a dodgy hip.

Kelly, from Penilee, found out about Nutrivive through a relative who used their CBD oil.

She said: I did some research and was quite impressed, so I thought I would give it a go.

After a couple of weeks putting half a dozen drops of Nutrivive CBD oil under my tongue, I noticed I wasnt suffering as much pain in my hips. And by the time Id finished my first bottle there was a massive difference and I couldnt wait to order another bottle.

I realised it was definitely the Nutrivive CBD that was making me pain-free because I went for a few weeks without taking the oil and my hip pain came back.

As soon as I started taking the Nutrivive again, the pain disappeared.

That really brought it home to me that the oil was working.

Its massively changed my life and I wouldnt be able to do the things many people take for granted if it wasnt for the CBD oil.

Harry expects his company will be one of the first to be accredited by the Food Standards Agency, which is bringing in new rules later this year to ensure quality standards of CBD products.

He said: Its a fantastic feeling knowing that our CBD oil has made a difference to Kelly and many other peoples lives.

I use it myself and I know first-hand the benefits it brings to me through relaxation, better sleep quality and how it holistically strengthens your mind, and body.

Visit http://www.nutrivive.co.uk for more information.

View post:

Mum tells how Paisley brothers' cannabis oil changed her life after years of pain - Daily Record

Cannabinoid Hemp Oil Market Research Report by Form (Concentrated Oil, Cream, Food Additive, Inhaled Liquids, and Supplement Capsule), by Source (Inorganic and Organic), by Distribution Mode, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19

New York, March 10, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Cannabinoid Hemp Oil Market Research Report by Form, by Source, by Distribution Mode, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p05940019/?utm_source=GNW

Market Statistics:The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global Cannabinoid Hemp Oil Market is expected to grow from USD 718.34 Million in 2020 to USD 3,081.56 Million by the end of 2025.2. The Global Cannabinoid Hemp Oil Market is expected to grow from EUR 629.86 Million in 2020 to EUR 2,701.97 Million by the end of 2025.3. The Global Cannabinoid Hemp Oil Market is expected to grow from GBP 559.94 Million in 2020 to GBP 2,402.06 Million by the end of 2025.4. The Global Cannabinoid Hemp Oil Market is expected to grow from JPY 76,666.01 Million in 2020 to JPY 328,881.37 Million by the end of 2025.5. The Global Cannabinoid Hemp Oil Market is expected to grow from AUD 1,043.13 Million in 2020 to AUD 4,474.84 Million by the end of 2025.

Market Segmentation & Coverage:This research report categorizes the Cannabinoid Hemp Oil to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Form, the Cannabinoid Hemp Oil Market studied across Concentrated Oil, Cream, Food Additive, Inhaled Liquids, Supplement Capsule, and Tincture Spray.

Based on Source, the Cannabinoid Hemp Oil Market studied across Inorganic and Organic.

Based on Distribution Mode, the Cannabinoid Hemp Oil Market studied across Offline Mode and Online Mode.

Based on Application, the Cannabinoid Hemp Oil Market studied across Cosmetics & Personal Care, Food & Beverage, Medical & Pharmaceuticals, and Pet Care.

Based on Geography, the Cannabinoid Hemp Oil Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Cannabinoid Hemp Oil Market including Aphria, Inc., Canopy Growth Corporation, CBD Health Solutions, LLC., CV Sciences, Inc., CW Hemp, Elixinol LLC, Endoca, Folium Biosciences, Freedom Leaf Inc., Green Roads of Florida, LLC, Isodiol International, Inc., Kazmira LLC, Medical Marijuana, Inc., NuLeaf Naturals LLC, and Pharmahemp.

Cumulative Impact of COVID-19:COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

360iResearch FPNV Positioning Matrix:The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Cannabinoid Hemp Oil Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

360iResearch Competitive Strategic Window:The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:1. Market Penetration: Provides comprehensive information on the market offered by the key players2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:1. What is the market size and forecast of the Global Cannabinoid Hemp Oil Market?2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cannabinoid Hemp Oil Market during the forecast period?3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cannabinoid Hemp Oil Market?4. What is the competitive strategic window for opportunities in the Global Cannabinoid Hemp Oil Market?5. What are the technology trends and regulatory frameworks in the Global Cannabinoid Hemp Oil Market?6. What are the modes and strategic moves considered suitable for entering the Global Cannabinoid Hemp Oil Market?Read the full report: https://www.reportlinker.com/p05940019/?utm_source=GNW

About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Story continues

See the original post here:

Cannabinoid Hemp Oil Market Research Report by Form, by Source, by Distribution Mode, by Application - Global Forecast to 2025 - Cumulative Impact of...